Why the study?
Does transcatheter aortic valve replacement reduce respiratory and non-respiratory complications compared to surgical aortic valve replacement in patients aged ≥60 with COPD?
Population
2,418 propensity-matched patients aged ≥60 years with chronic obstructive pulmonary disease undergoing…
Comparison
Transarterial transcatheter aortic valve… vs Surgical aortic valve replacement (SAVR)
Design
Cohort
Follow-up
in-hospital
Authors
Loading...
May support TAVR preference in older COPD patients to reduce respiratory risks; leaves open need for randomized confirmation.
Does transcatheter aortic valve replacement reduce respiratory and non-respiratory complications compared to surgical aortic valve replacement in patients aged ≥60 with COPD?
In patients aged ≥60 with COPD, TAVR is associated with significantly fewer in-hospital respiratory complications, lower mortality, shorter hospital stays, and lower costs compared to SAVR.
Ando et al. (2018) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: